Capellon Pharmaceuticals, LLC
Records under this name other than the patents Capellon Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Capellon Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,098,856 | Alternating Sympathomimetic Therapy for the Treatment of Respiratory Ailments Lapsed on the fee record Ended Oct 16, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 16, 2026 | Low confidence |
| US 8,653,135 | Alternating Sympathomimetic Therapy for the Treatment of Respiratory Ailments Lapsed on the fee record Ended Feb 18, 2026 · High confidence | Lapsed on the fee record | Ended Feb 18, 2026 | High confidence |
| US 9,492,541 | Phenylepherine Containing Dosage Form Lapsed on the fee record Ended Nov 15, 2024 · Medium confidence | Lapsed on the fee record | Ended Nov 15, 2024 | Medium confidence |
| US 9,364,451 | Alternating Sympathomimetic Therapy for the Treatment of Respiratory Ailments Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |
| US 9,844,538 | Hyoscyamine Dosage Form Lapsed on the fee record Ended Dec 19, 2021 · High confidence | Lapsed on the fee record | Ended Dec 19, 2021 | High confidence |